Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Taro Pharmaceutical Indus Q1 EPS $0.27 Down From $0.37 YoY, Sales $158.89M Up From $156.66M YoY

Author: Benzinga Newsdesk | July 27, 2023 02:40am
Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.27 per share. This is a 27.03 percent decrease over earnings of $0.37 per share from the same period last year. The company reported $158.89 million in sales this quarter. This is a 1.42 percent increase over sales of $156.66 million the same period last year.

Posted In: TARO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist